Interaction of melatonin and Bmal1 in the regulation of PI3K/AKT pathway components and cellular survival

被引:0
|
作者
Mustafa C. Beker
Berrak Caglayan
Ahmet B. Caglayan
Taha Kelestemur
Esra Yalcin
Aysun Caglayan
Ulkan Kilic
Ahmet T. Baykal
Russel J. Reiter
Ertugrul Kilic
机构
[1] Istanbul Medipol University,Regenerative and Restorative Medicine Research Center
[2] School of Medicine,Department of Physiology
[3] Istanbul Medipol University,Department of Medical Biology
[4] International School of Medicine,Department of Medical Biology, School of Medicine
[5] Istanbul Medipol University,Department of Medical Biochemistry
[6] University of Health Sciences,Department of Cell Systems and Anatomy
[7] School of Medicine,undefined
[8] Acibadem Mehmet Ali Aydinlar University,undefined
[9] UT Health San Antonio,undefined
来源
Scientific Reports | / 9卷
关键词
D O I
暂无
中图分类号
学科分类号
摘要
The circadian rhythm is driven by a master clock within the suprachiasmatic nucleus which regulates the rhythmic secretion of melatonin. Bmal1 coordinates the rhythmic expression of transcriptome and regulates biological activities, involved in cell metabolism and aging. However, the role of Bmal1 in cellular- survival, signaling, its interaction with intracellular proteins, and how melatonin regulates its expression is largely unclear. Here we observed that melatonin increases the expression of Bmal1 and both melatonin and Bmal1 increase cellular survival after oxygen glucose deprivation (OGD) while the inhibition of Bmal1 resulted in the decreased cellular survival without affecting neuroprotective effects of melatonin. By using a planar surface immunoassay for PI3K/AKT signaling pathway components, we revealed that both melatonin and Bmal1 increased phosphorylation of AKT, ERK-1/2, PDK1, mTOR, PTEN, GSK-3αβ, and p70S6K. In contrast, inhibition of Bmal1 resulted in decreased phosphorylation of these proteins, which the effect of melatonin on these signaling molecules was not affected by the absence of Bmal1. Besides, the inhibition of PI3K/AKT decreased Bmal1 expression and the effect of melatonin on Bmal1 after both OGD in vitro and focal cerebral ischemia in vivo. Our data demonstrate that melatonin controls the expression of Bmal1 via PI3K/AKT signaling, and Bmal1 plays critical roles in cellular survival via activation of survival kinases.
引用
收藏
相关论文
共 50 条
  • [21] PI3K/AKT/mTOR pathway in angiogenesis
    Karar, Jayashree
    Maity, Amit
    FRONTIERS IN MOLECULAR NEUROSCIENCE, 2011, 4
  • [22] Activation of the PI3K/Akt pathway in neuroblastoma
    Sartelet, Herve
    Castaing, Marine
    Fabre, Monique
    Bosq, Jacques
    Rougemont, Anne-Laure
    Michieis, Stefan
    Vassal, Gilles
    VIRCHOWS ARCHIV, 2007, 451 (02) : 130 - 130
  • [23] The PI3K/Akt/mTOR signaling pathway
    Dennis, P. A.
    ANNALS OF ONCOLOGY, 2011, 22 : 19 - 19
  • [24] Overview of the PI3K/Akt/mTOR pathway
    Dennis, P. A.
    ANNALS OF ONCOLOGY, 2008, 19 : 21 - 21
  • [25] Activation of the PI3K/Akt pathway in neuroblastoma
    Sartelet, H.
    Castain, M.
    Fabre, M.
    Bosq, J.
    Rougemont, A.
    Michiels, S.
    Vassal, G.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [26] The PI3K/AKT/mTOR interactive pathway
    Ersahin, Tulin
    Tuncbag, Nurcan
    Cetin-Atalay, Rengul
    MOLECULAR BIOSYSTEMS, 2015, 11 (07) : 1946 - 1954
  • [27] PI3K/Akt signalling pathway and cancer
    Vara, JAF
    Casado, E
    de Castro, J
    Cejas, P
    Belda-Iniesta, C
    González-Barón, M
    CANCER TREATMENT REVIEWS, 2004, 30 (02) : 193 - 204
  • [28] PI3K regulates BMAL1/CLOCK-mediated circadian transcription from the Dbp promoter
    Morishita, Yoshikazu
    Miura, Daiki
    Kida, Satoshi
    BIOSCIENCE BIOTECHNOLOGY AND BIOCHEMISTRY, 2016, 80 (06) : 1131 - 1140
  • [29] ENKUR Is Involved in the Regulation of Cellular Biology in Colorectal Cancer Cells via PI3K/Akt Signaling Pathway
    Ma, Qing
    Lu, Yin
    Gu, Ye
    TECHNOLOGY IN CANCER RESEARCH & TREATMENT, 2019, 18
  • [30] Regulation and Importance of the PI3K/Akt/mTOR Signaling Pathway in Hematologic Malignancies
    Kawauchi, Kiyotaka
    Ogasawara, Toshie
    Yasuyama, Masako
    Otsuka, Kuniaki
    Yamada, Osamu
    ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY, 2009, 9 (09) : 1024 - 1038